ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 78 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $136,000 | -55.7% | 133,840 | -39.9% | 0.02% | -59.5% |
| Q2 2021 | $307,000 | -14.7% | 222,619 | +4.9% | 0.04% | -36.2% |
| Q1 2021 | $360,000 | +37.4% | 212,238 | +0.1% | 0.06% | +5.5% |
| Q4 2020 | $262,000 | -13.0% | 212,052 | 0.0% | 0.06% | -25.7% |
| Q3 2020 | $301,000 | +144.7% | 212,052 | +108.0% | 0.07% | +111.4% |
| Q2 2020 | $123,000 | -0.8% | 101,965 | -2.7% | 0.04% | -16.7% |
| Q1 2020 | $124,000 | – | 104,795 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,731,342 | $8,022,000 | 0.40% |
| WealthTrust Axiom LLC | 210,000 | $451,000 | 0.17% |
| Palo Alto Investors LP | 1,032,715 | $2,220,000 | 0.10% |
| ELEMENT CAPITAL MANAGEMENT LLC | 144,536 | $311,000 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $107,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $152,000 | 0.03% |
| LMR Partners LLP | 148,309 | $319,000 | 0.02% |
| LINCOLN CAPITAL CORP | 10,000 | $22,000 | 0.02% |
| Malaga Cove Capital, LLC | 13,150 | $28,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $65,000 | 0.01% |